Loading...
Market
Will a peer-reviewed study on Rapamycin's effectiveness in dogs be published by mid-2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Publication in a reputable scientific journal
Story
Scientists Develop Drugs, Including mTOR Inhibitor Rapamycin, to Extend Lifespan of Dogs with Implications for Human Longevity
Dec 27, 2024, 05:42 AM
Researchers are exploring new drugs aimed at extending the lifespan of dogs, which may have implications for human longevity. Current studies focus on the development of a pill that could prolong the lives of dogs, with scientists suggesting that similar effects might be applicable to humans. This follows the previous identification of the mTOR inhibitor, Rapamycin, as the only molecule rigorously proven to increase lifespan in healthy mice across various studies. The ongoing research into canine longevity could pave the way for advancements in human health and lifespan extension.
View original story
Similar markets
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
